Legacy Wealth Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$743K Buy
1,496
+1
+0.1% +$443 0.16% 194
2026
Q1
$668K Buy
1,495
+12
+0.8% +$5.6K 0.16% 212
2025
Q4
$672K Buy
1,483
+41
+3% +$17.7K 0.17% 200
2025
Q3
$565K Buy
1,442
+26
+2% +$10.9K 0.14% 236
2025
Q2
$630K Sell
1,416
-13
-0.9% -$5.99K 0.16% 202
2025
Q1
$693K Sell
1,429
-22
-2% -$10.3K 0.19% 164
2024
Q4
$584K Sell
1,451
-7
-0.5% -$3.25K 0.16% 206
2024
Q3
$678K Buy
1,458
+12
+0.8% +$5.76K 0.18% 181
2024
Q2
$678K Sell
1,446
-2,938
-67% -$1.28M 0.19% 154
2024
Q1
$1.83M Sell
4,384
-8
-0.2% -$3.38K 0.51% 49
2023
Q4
$1.79M Sell
4,392
-12
-0.3% -$4.43K 0.59% 45
2023
Q3
$1.53M Buy
4,404
+17
+0.4% +$5.95K 0.56% 48
2023
Q2
$1.54M Buy
4,387
+1,164
+36% +$392K 0.54% 45
2023
Q1
$1.02M Buy
3,223
+8
+0.2% +$2.4K 0.37% 76
2022
Q4
$928K Buy
3,215
+6
+0.2% +$1.83K 0.35% 85
2022
Q3
$929K Buy
+3,209
New +$923K 0.41% 75

Other funds holding VRTX